Description
Four peptides from four structural classes, co-lyophilized in a single vial. GHK-Cu is a metallopeptide — a copper(II) complex rather than a peptide alone, which is why it carries both a complex and an apo-peptide registry entry. BPC-157 is a pentadecapeptide corresponding to a region of human gastric juice protein. TB-500 is a seven-residue acetylated fragment of thymosin β4, not the full-length 43-residue protein. KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone.
Each component is investigated individually in in-vitro systems — metal-coordination chemistry for GHK-Cu, actin binding for BPC-157 and TB-500, NF-κB pathway assay behavior for KPV. No combination data exists for this four-component mixture, and none is presented, referenced, or implied. Per-component mass breakdown is stated on the certificate of analysis for each lot.
Supplied strictly for laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or animal consumption, and not for diagnostic or therapeutic use. Purchase confirms the buyer is a qualified researcher and accepts sole responsibility for lawful handling, storage, and disposal under all applicable regulations.
Specifications
| Component | CAS Number | Residues |
|---|---|---|
| GHK-Cu (copper tripeptide-1) | 89030-95-5 | 3 + Cu(II) |
| BPC-157 | 137525-51-0 | 15 |
| TB-500 (Tβ4 17–23, N-acetylated) | 885340-08-9 | 7 |
| KPV (α-MSH 11–13) | 67727-97-3 | 3 |
| Total peptide per vial | 80mg |
|---|---|
| Purity | ≥99% RP-HPLC per component |
| Form | Co-lyophilized powder |
| Presentation | 10 vials × 80mg |
| Storage | −20°C, protect from light |
